Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



[Pinned] OBN concludes hugely successful BioTrinity 2018 conference

Leading annual life sciences event attracted more than 160 company CEOs, in excess of 150 leading investors and over 80 major pharmaceutical company delegates

Read the rest of entry »

J A Kemp Expands in Cambridge

J A Kemp has relocated its Cambridge office today, 14 May, to larger, more modern premises on Capital Park. The firm is more than doubling its office space in Cambridge.

Read the rest of entry »

High Throughput Gene Expression Analysis Service

AMSBIO, a global provider of gene editing and personalized medicine technologies, has launched a service for high throughput gene expression analysis. 

Read the rest of entry »

UK Government offer £2,500 funding support for UK exhibitiors

The UK Government and the Department for International Trade (DIT) are therefore keen to support UK exhibitors at the event, by offering funding support in the form of TAP Grants* at the value of £2,500.

Read the rest of entry »

Aptus Clinical - Ready for Growth

It’s only May and it has already been quite a year for Aptus Clinical. We have added several exceptional individuals to our team, given a well-deserved internal promotion and restructured to ensure efficient project management, seamless client liaison and access to our exceptional talent is at the heart of the client experience.

Read the rest of entry »

Foresight makes £3.5m growth capital investment into Mologic

Investment to support launch of sepsis, COPD and infectious disease diagnostics and international expansion of Contract Research business.

Read the rest of entry »

Chronos Therapeutics Announces Positive Pre-Clinical Proof of Concept Studies for its Orexin-1 Antagonist Project Initially Targeting Binge Eating Disorder

Chronos Therapeutics Ltd (Chronos) the private biotech company focused on ageing diseases, brain and nervous system disorders, announced today that the lead compound in its addiction programme, CT-010018 an orexin-1 antagonist, demonstrated positive pre-clinical proof of concept (POC) results in an in vivo model of binge eating disorder (BED).

Read the rest of entry »

Oxford Expression Technologies is Awarded £2 Million Vaccine Development Contract

Oxford Expression Technologies Ltd (OET) is pleased to announce that it has been awarded a £2M contract from Innovate UK to continue its ongoing work in developing the first economically viable vaccine against Crimean Congo Haemorrhagic Fever (CCHF) virus.

Read the rest of entry »

 Business Development Manager (Energy)

Do you have experience of selling energy procurement contracts into the I&C retail UK Energy Industry? A leading Gas and Electricity consultants is seeking a Business Development Manager to join their Coventry based team, to enhance the company’s position in terms of both new sales and margin growth

Read the rest of entry »

Mologic Signs Agreements with Medisur and Peripal to Distribute PERIPLEX POC Diagnostic in Europe

Mologic Ltd, a developer of powerful, personalised diagnostics to improve the lives of patients, today announced that it has signed agreements with medical technology companies, Medisur and Peripal AG to distribute PERiPLEX®

Read the rest of entry »

Pages: Previous1234567...36NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.